
Study Indicates NMN Has Anti-Aging Potential for Kidneys
NMN’s restoration of youthful kidney protein levels in aged mice may translate therapeutically to humans. The world’s population of older adults co...
Read moreFree shipping on order over $50 in US or $500 outside US
NR supplementation improves mitochondrial function and affects inflammatory response in heart failure patients Although inflammation is a way that ...
Read moreThe addition of Disarm's promising programs for axonal degeneration expands Eli Lilly and Company’s R&D efforts in pain and neurodegeneration. ...
Read moreNR supplementation provides a novel heart failure therapy by preserving cardiac function and blocking inflammation. Although inflammation is a way ...
Read moreScientists find NMN improves depression-like behavior, displayed as immobility in swim tests, and cellular energy production in mice. About 16.2 mi...
Read moreSkin cells treated with a form of vitamin B3 activates DNA repair programs. While many people love getting some sun, they know how damaging catchin...
Read moreA new study indicates age-related inflammation can stimulate CD38 positive immune cell consumption of NAD+. An essential molecule for cellular ener...
Read moreNicotinamide mononucleotide (NMN) intervention protects neurons and memory from diabetes-induced brain degeneration in rats. The brains of many peo...
Read moreMiscommunication between mitochondria and the nucleus accelerates aging, but NAD+ supplementation helps restore the conversation and reverses signs...
Read moreNAD+ metabolism drives tumor escape from the immune response, but boosting NAD+ levels improves the efficacy of anti-cancer therapy. Nicotinamide ...
Read moreNR supplementation alleviates defects in cells from dyskeratosis congenita patients. Stretches of repetitive DNA called telomeres stop the ends of ...
Read moreNAD+ precursor decreases atrial fibrillation susceptibility and duration in mice. Aging and obesity are prominent risk factors for the onset of atr...
Read moreInvestigators propose that a newly revealed nicotinamide adenine dinucleotide (NAD+) binding site of Sarm1 may be a promising drug target. Degenera...
Read more